Unpacking the GLP-1 Gold Rush
We ask experts for their views on the GLP-1 market in this exclusive eBook. GLP-1 receptor agonists have rapidly evolved from niche diabetes drugs to headline-grabbing agents of a global weight-loss revolution. But the science, strategy, and scale behind these therapies are far more complex than the public narrative suggests. This exclusive eBook, The GLP-1 Gold […]
Could Ozempic Treat Migraines, Too? Small Study Finds Early Promise for GLP-1s
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.
GLP-1s in Neurodegenerative Disease: Hope or Halt?
Neurologists Indu Subramanian and Lorraine Kalia discuss the data on GLP-1 receptor agonists in neurodegenerative diseases and the recent study on exenatide in Parkinson’s disease. Medscape Neurology
Many People Actually Lose Muscle on a GLP-1. It’s Not Too Hard to Avoid—Here’s How.
This protocol will help.
New book by former FDA head explores the science behind GLP-1 weight loss drugs
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained weight loss. In a new book, former FDA head Dr. David Kessler advocates for their use, but says they shouldn’t be […]
With China approval, Lilly and Innovent’s mazdutide breaks into new class for GLP-1 obesity drugs – Fierce Pharma
With China approval, Lilly and Innovent’s mazdutide breaks into new class for GLP-1 obesity drugs Fierce Pharma
OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025
OPKO Health, Inc. (NASDAQ:OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the company, in partnership with Entera Bio Ltd., announced that new data for their investigational oral OPK-88006 tablet treatment has been selected for presentation at ENDO 2025. 15 States with the Best Healthcare in […]
Dietitian Who Lost 60 Pounds With GLP-1 Drug Reveals Foods to Avoid and Prioritize
